In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

September 24, 2018
Allergan's Discovery Buck-Passing Rejected In Opioid MDL

Allergan PLC can't avoid coughing up documents about its sales of narcotic painkillers even though Teva Pharmaceutical Industries Ltd. recently acquired the painkillers' rights and legal liabilities, according to a new ruling in multidistrict litigation over the opioid epidemic.
September 20, 2018
New MDL Needed For 'Opioid Babies,' Attys Say

Attorneys for "opioid babies" whose mothers used prescription narcotics argued on Thursday for new multidistrict litigation focused on the infants, citing "grave concerns" that an existing MDL over the opioid crisis is woefully deficient.
September 17, 2018
Opioid MDL Stakes Rise For Pharmacy Benefit Cos.

The nation's biggest pharmacy benefit management companies should be forced to clamp down on painkiller prescriptions, according to a new motion that raises the stakes for PBMs in multidistrict litigation over the opioid epidemic and contains fresh signs of friction among plaintiffs attorneys.
September 05, 2018
Tribes Can't Have Opioid Suits Sent To State Court From MDL

An Ohio federal judge rejected bids by two tribes to remand to state court their suits against McKesson Corp. and other companies over the opioid crisis, ruling that the claims belong in federal court because McKesson was subject to federal control under a government contract when it allegedly allowed the drugs to be diverted.
September 04, 2018
Tribe Can't Fault Generics Cos. For Opioid Crisis, Court Told

A group of generic-drug makers pushed back at a Montana tribe's attempt in multidistrict litigation ongoing in Ohio federal court to hold them liable for the opioid epidemic, saying they shouldn't be lumped in with their brand-name counterparts because they operate under a different business model.
August 31, 2018
Pharma Cases To Watch In 2018's Home Stretch

Drugmakers in the closing months of 2018 may see pivotal rulings on novel efforts to hamstring rival medicines, escalating drama in multidistrict litigation over the opioid epidemic, and opening salvos in False Claims Act and drug-pricing fights at the U.S. Supreme Court. Here, Law360 summarizes key cases to watch.
August 21, 2018
Attys Relaunch Bid For 'Opioid Babies' Track In MDL

Attorneys representing babies born to mothers who took prescription narcotics while pregnant renewed their push Tuesday for a separate track in the opioid multidistrict litigation, telling an Ohio federal judge that they're being stonewalled by the plaintiffs' executive committee.
August 13, 2018
States Push Back Against Dismissal Bids In Opioid MDL

Dozens of states slammed a bid by drugmakers and distributor McKesson Corp. to dismiss claims that they fueled the opioid crisis, telling an Ohio federal judge who is overseeing the opioid multidistrict litigation that a state's ability to protect the health of its citizens must not be restricted.
August 13, 2018
Opioid MDL Bellwether Trial Postponed 6 Months

An Ohio federal judge on Monday delayed the first bellwether trial in multidistrict litigation over the opioid epidemic by nearly six months to September 2019, the latest sign that dreams of quickly resolving the epic legal battle may not be realized.
August 06, 2018
Providers Say Don't Kill Hospital Bellwether In Opioid MDL

A coalition of 44 hospitals that say they are on the front lines of treating the opioid epidemic on Friday asked to weigh in on multidistrict litigation over the opioid crisis, arguing that efforts to dismiss a bellwether lawsuit for hospitals should be rejected.

← Previous
…
39
40
41
42
43
44
45
46
47
48
Next →